Headaches in patients with systemic lupus erythematosus: A comparative study

Lupus

Volumn 13, Issue 7, 2004, Pages 501-505

  Whitelaw, D A ^a,b   Hugo, F ^a   Spangenberg, J J ^a   Rickman, R ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

ACA syndrome; Control group; Lupus activity; Migraine; Stress factors

Indexed keywords

CARDIOLIPIN ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEADACHE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RAYNAUD PHENOMENON; STRESS; SYSTEMIC LUPUS ERYTHEMATOSUS; TENSION HEADACHE;

ADOLESCENT; ADULT; EDUCATIONAL STATUS; FEMALE; HEADACHE; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NURSES; RAYNAUD DISEASE; REFERENCE VALUES;

EID: 4043165482     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203304lu1050oa     Document Type: Article

References (28)

1. Brey RL, Holliday SL, Saklad AR et al. Neuropsychiatric syndromes in lupus. Neurology 2001; 58: 1214-1220.
2. Mok CC, Lau CS, Wong RWS. Neuropsychiatric manifestations and their clinical associations in Southern Chinese patients with systemic lupus erythematosus. J Rheumatol 2001; 28: 766-771.
3. Lim L, Ron MA, Ormerod IEC. Psychiatric and neurological manifestations in systemic lupus erythematosus. Q J Med 1988; 66: 27-38.
4. Anzola GP, Dalla Volta G, Balestrieri G. Headache in patients with systemic lupus erythematosus: clinical and telethermographic findings. Arch Neurol 1988; 45: 1061-1062.
5. Omdal R, Waterloo K, Koldingsnes W, Husby G, Mellgren SI. Somatic and psychological features of headache in systemic lupus erythematosus. J Rheumatol 2001; 28: 772-779.
6. Vazquez-Cruz J, Traboulssi H, Rodriquez- De la Sema A et al. A prospective study of chronic or recurrent headache in systemic lupus erythematosus. Headache 1990; 30: 232-235.
7. Eisenberg DA, Meyrick-Thomas D, Snaith ML, McKeran RO, Royston JP. A study of migraine in systemic lupus erythematosus. Ann Rheum Dis 1982; 41: 30-32.
8. Sanna G, Bertolaccini ML, Cuadrado MJ et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003; 30: 985-992.
9. Kaell AT, Shetty M, Lee BCP, Lockshin MD. The diversity of neurologic events in systemic lupus erythematosus. Arch Neurol 1986; 43: 273-276.
10. Markus HS, Hopkinson N. Migraine and headache in systemic lupus erythematosus and their relationship with antibodies against phospholipids. J Neurol 1992; 239: 39-42.
11. Bombardier C, Gladmann DD, Urowitz MB et al. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-639.
12. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature: The American College of Rheumatology nomenclature and case definitions for neuropsychiatric syndromes. Arthritis Rheum 1999; 42: 599-608.
13. Sfikakis PP, Mitsikostas DD, Manoussakis MN, Foukanelli, Moutsopoulos HM. Headaches in systemic lupus erythematosus: a controlled study. Br J Rheumatol 1998; 37: 300-303.
14. Fernandez-Nebro A, Palacios-Munoz R, Gordillo J et al. Chronic or recurrent headache in patients with systemic lupus erythematosus: a case control study. Lupus 1999; 8: 151-156.
15. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. JAMA 1992; 267: 64-69.
16. Hugo FJ, Halland AM, Spangenberg JJ et al. DSM-III-R Classification of psychiatric symptoms in systemic lupus erythematosus. Psychosomatics 1996; 37: 262-269.
17. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 7: 1-96.
18. Miller D, Waters DD, Warnica W, Szlachcic J, Kreeft J, Theroux P. Is variant angina the coronary manifestation of a generalised vasospastic disorder? N Engl J Med 1981; 304: 763-766.
19. Whitelaw DA, Spangenberg JJ, Rickman R, Hugo FH, Roberts M. The association between the antiphospholipid antibody syndrome and neuropsychological impairment in SLE. Lupus 1999; 8: 444-448.
20. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on the preliminary classification criteria for definite antiphosphoplipid syndrome. Arthritis Rheum 1999; 42: 1309-1311.
21. Omdal R, Mellgren SI, Husby G. Clinical neuropsychiatric and neuromuscular manifestations in systemic lupus erythematosus. Scan J Rheumatology 1988; 17: 113-117.
22. Sanchez-Perez R, Asensio M, Melchor A et al. Clinical features of migraine according to the questionnaire 'Alcoi 92' in the Comtat area. Rev Neurol 1999; 28: 459-463.
23. Glanz BI, Venkatesan A, Schur PH et al. Prevalence of migraine in patients with systemic lupus erythematosus. Headache 2001; 41: 285-289.
24. Amit M, Molad Y, Levy O, Wysenbeek AJ. Headache in systemic lupus erythematosus and its relation to other disease manifestations. Clin Exp Rheumatol 1999; 17: 467-470.
25. Kovacs JA, Urowitz MB, Gladman DD. Dilemmas in neuropsychiatric lupus. Rheum Dis Clin of N Am 1993; 19: 795-812.
26. Alarcon-Segovia D, Estanol B, Garcia-Ramos G, Villa AR. Antiphospholipid antibodies and the antiphospholipid syndrome. Clinical relevance in neuropsychiatric systemic lupus erythematosus. Ann NY Acad Sci 1997; 823: 279-288.
27. Levine SR, Welch KMA. The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies. Arch Neurol 1987; 44: 876-882.
28. Cuadrado MJ, Sanna G. Headache and systemic lupus erythematosus. Lupus 2003; 12: 943-946.